MOUNT PLEASANT, MI / / February 5, 2026 / Isabella Bank Corporation (Nasdaq:ISBA) ("Isabella" or the "Company") reported net ...
A cohort of 20 university teams will vie for a chance to collaborate with industry partners and bring their designs to life ...
Hands-on experience with professional tools remains limited in PR classrooms nationwide due to perceived cost barriers ...
MURFREESBORO, TN / ACCESS Newswire / February 2, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today that it invested $105.5 million, including transaction costs, for the acquisition of ...
Jim Chalmers talks a lot about tax reform, but this is a government so timid the chances of it doing anything meaningful are ...
LYNNWOOD, WA / ACCESS Newswire / / U & I Financial Corp. (OTCQX:UNIF), the holding company ("Company") for UniBank ("Bank"), ...
Memorial i li Hospital's Nuclear Oncology and Theranostics Unit delivers advanced diagnostic and radioactive therapies for prostate cancer, neuroendocrine tumors, and selected solid tumors within the ...
Memorial Şişli Hospital’s Nuclear Oncology and Theranostics Unit delivers advanced diagnostic and radioactive therapies for ...
ORLANDO, FL / ACCESS Newswire / January 26, 2026 / RedChip Companies will host an investor webinar with First Phosphate Corp.
MCLEAN, VA / ACCESS Newswire / January 22, 2026 / Gladstone Commercial Corporation (NASDAQ:GOOD) ("Gladstone Commercial") is pleased to report another successful year of investing, leasing, and dispos ...
Combination of ZG005 with etoposide and cisplatin (EP) vs. EP as the first-line therapy for advanced neuroendocrine carcinoma: A randomized, multicenter, phase I/II trial. This is an ASCO Meeting ...
Perspective Therapeutics' novel alpha emitter PRRT shows promise in early trials, with manageable toxicity and durable disease control in GEP-NETs and melanoma. Strong cash position allows CATX to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results